Is ERYP or DVY a better dividend investment in 2026?

ERYP currently yields 256.41% with a 5% 5-year dividend growth rate. DVY yields 3.50% with 5% growth. The better choice depends on your goal: ERYP offers higher current income.

What is the dividend yield difference between ERYP and DVY?

ERYP has a forward dividend yield of 256.41% ($2.00/share annually). DVY yields 3.50% ($5.25/share annually). The yield gap is 252.91 percentage points.

Home › Compare › ERYP vs DVY

ERYP vs DVY: Dividend Comparison 2026

ERYP yields 256.41% · DVY yields 3.50%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ERYP wins by $541.20M in total portfolio value

INVESTMENT

TIME HORIZON10 years

ERYP

● Live price

256.41%

Share price

$0.78

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$541.22M

Annual income

$306,262,465.48

Full ERYP calculator →

DVY

● Live price

3.50%

Share price

$150.03

Annual div

$5.25

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.1K

Annual income

$437.78

Full DVY calculator →

Portfolio growth — ERYP vs DVY

📍 ERYP pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ERYP	DVY
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ERYP + DVY cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ERYP pays

DVY pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ERYP

Annual income on $10K today (after 15% tax)

$21,794.87/yr

After 10yr DRIP, annual income (after tax)

$260,323,095.66/yr

DVY

Annual income on $10K today (after 15% tax)

$297.17/yr

After 10yr DRIP, annual income (after tax)

$372.11/yr

At 15% tax rate, ERYP beats the other by $260,322,723.55/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ERYP + DVY for your $10,000?

ERYP: 50%DVY: 50%

100% DVY50/50100% ERYP

Portfolio after 10yr

$270.62M

Annual income

$153,131,451.63/yr

Blended yield

56.58%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on ERYP right now

ERYP

Analyst Ratings

Buy

Consensus: Buy

Altman Z

1.9

Piotroski

2/9

DVY

No analyst data

Altman Z

307.5

Piotroski

1/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ERYP buys

DVY buys

No recent congressional trades found for ERYP or DVY in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricERYPDVY

Forward yield	256.41% ✓	3.50%
Annual dividend / share	$2.00	$5.25 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$541.22M ✓	$25.1K
Annual income after 10y	$306,262,465.48 ✓	$437.78
Total dividends collected	$516.37M ✓	$4.0K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: ERYP vs DVY ($10,000, DRIP)

Year	ERYP Portfolio	ERYP Income/yr	DVY Portfolio	DVY Income/yr	Gap
1← crossover	$36,341	$25,641.03	$11,050	$349.62	+$25.3K → ERYP
2	$125,971	$87,086.09	$12,184	$361.04	+$113.8K → ERYP
3	$416,912	$282,122.92	$13,409	$372.07	+$403.5K → ERYP
4	$1,318,722	$872,626.36	$14,730	$382.68	+$1.30M → ERYP
5	$3,990,640	$2,579,607.07	$16,154	$392.89	+$3.97M → ERYP
6	$11,565,551	$7,295,566.53	$17,688	$402.69	+$11.55M → ERYP
7	$32,135,691	$19,760,551.21	$19,338	$412.07	+$32.12M → ERYP
8	$85,699,274	$51,314,084.97	$21,113	$421.04	+$85.68M → ERYP
9	$219,589,910	$127,891,686.63	$23,020	$429.61	+$219.57M → ERYP
10	$541,223,669	$306,262,465.48	$25,070	$437.78	+$541.20M → ERYP

ERYP vs DVY: Complete Analysis 2026

ERYP — Stock

ERYTECH Pharma S.A., a clinical-stage biopharmaceutical company, develops red blood cell-based therapeutics for cancer and orphan diseases in France and the United States. Its lead product candidate is eryaspase, which is in Phase 3 clinical development for the treatment of second-line pancreatic cancer, and in Phase 2 stage for the treatment of triple-negative breast cancer and second-line acute lymphoblastic leukemia patients. The company also engages in developing erymethionase, a preclinical product candidate that consists of methionine-?-lyase in red blood cells to target methionine cancers. The company was incorporated in 2004 and is headquartered in Lyon, France.

Full ERYP Calculator →

DVY — ETF

The iShares Select Dividend ETF seeks to track the investment results of an index composed of relatively high dividend paying U.S. equities.

Full DVY Calculator →

📬

Get this ERYP vs DVY comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ERYP vs SCHD ERYP vs JEPI ERYP vs O ERYP vs KO ERYP vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.